SCI(2013): 8.559

(0) 讚！ | 凌霄高洁

Is there a charge for the oncogene?

(0) 讚！ | 凌霄高洁

Review speed: 2.0 experience sharing: Just passed one without being as difficult as imagined. Emphasize innovation

(0) 讚！ | 凌霄高洁

It has been eight days since submission, and now the status is "EIC Decision Started." Does this mean rejection?

(0) 讚！ | 凌霄高洁

Review Speed: 1.0 Experience Sharing: Just got a paper accepted, which requires high innovation. The opinions of the two reviewers are very constructive, with only a few additional experiments needed. You can give it a try. I am in the field of oncology

(0) 讚！ | 凌霄高洁

Review Speed: 1.0 Experience Sharing: Initial review 10 days, first review one month, revision 3 months, average acceptance time 4 months

(0) 讚！ | 凌霄高洁

An article has been rejected, and I am very sad!!! 555~~~

(0) 讚！ | 凌霄高洁

There are currently two MANUSCRIPTS on ONCOGENE, one has already started the review process, and the other is still in the initial review... Both articles are silently working hard... Hopefully they can both be revised

(0) 讚！ | 凌霄高洁

The day turned tragic, it's so heartbreaking!

(0) 讚！ | 凌霄高洁

The Oncogene magazine is relatively easy compared to others. It has strict requirements for innovation but slightly lower requirements for logic

(0) 讚！ | 凌霄高洁

Review speed: 2.0 | Submission hit rate: 25.0
Experience sharing: For high-quality articles nowadays, such as the behavior of tumors, it is necessary to validate with two different cell lines simultaneously for more reliable data. The same goes for using pharmacological inhibitors, where two inhibitors are needed (unless only one is available), or utilizing genetic literature for gene silencing or overexpression studies

(0) 讚！ | 凌霄高洁

When publishing an article on the invasion and metastasis of tumor cells, it is necessary to verify in two or more types of cells

(0) 讚！ | 是来普吖

Acceptance rate: 50.0 
Experience sharing: Chinese people contribute a lot of articles, and many Chinese researchers in basic research like to submit to this journal. Compared to other high-level cancer journals, it is easy to be accepted. Highly recommended~

(0) 讚！ | 凌霄高洁

Submission success rate: 25.0 Experience sharing: Several of my friends working on basic research have been published in Oncogene. I strongly recommend Chinese researchers to submit... The success rate is between 30-45%

(0) 讚！ | 凌霄高洁

It's been 11 days since the submission, but it's still in the initial review stage and in the hands of the editor. I wonder what they are considering?

(0) 讚！ | 凌霄高洁

甚至：Just submitted an article and the status changed to "decision made" after a week. Not sure if there's still hope

(0) 讚！ | 凌霄高洁

Please be aware of a person named Wu WK, his email address is wukk1980@gmail.com. I suspect he intends to swindle money from those who are eager to publish articles and lack confidence in their own writing. Today, while searching for submission magazines, I saw that he claimed to have submitted an article to many different magazines. If you need further information, please contact him. How amazing is he? Can someone really publish so many articles in different fields and magazines? Since authors' names in SCI are not in Chinese characters and often in phonetic transliterations, it is very possible for someone to plagiarize articles under the same name. Please be cautious!

(0) 讚！ | 凌霄高洁

Review Speed: 1.0 Experience Sharing: The review cycle for my paper is somewhat different from what the previous individuals mentioned. Generally speaking, it feels quite fast, and the editor's attitude has always been calm. However, the opinions of the two reviewers were very consistent, and they requested similar experiments to be added. I submitted the paper at the end of January, received a major revision response in almost 4 weeks, and was given 3 months to conduct additional experiments. After completing the revisions in around 80 days, I resubmitted the paper and received a response in less than 4 weeks. After making slight modifications, the paper was accepted, taking approximately 5 months in total

(0) 讚！ | Paula Back

The review period is not accurate. This journal usually takes more than 2 months for reviews, and it's the kind where you hear nothing. Many articles take nearly a year from submission to acceptance

(0) 讚！ | 凌霄高洁

Just published a review article. Wu WK, et al. MicroRNA dysregulation in gastric cancer: a new player enters the game. Oncogene (In press) doi:10.1038/onc.2010.352. Interested in collaboration, please email wukk1980@gmail.com

(0) 讚！ | 凌霄高洁

One of the leader journals in the area of ​​oncology.

(0) 讚！ | 匿名

Why did I submit my manuscript in early July but only received the first round of reviewer comments in September? And both reviewers' comments were not inconsistent at all

(0) 讚！ | 凌霄高洁

Tumors are more likely to be published, emphasizing innovation, emphasizing basic research, and compared to cancer research, it emphasizes basic research and novelty, generally good for publishing articles on topics such as tumor cell apoptosis, tumor stem cells, etc. The requirements for the rigor of the research are not very high. Many articles published domestically

(0) 讚！ | 凌霄高洁